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ABSTRACT

This invention relates to plants having modified reproduc
tive capacity. In particular, it relates to a plant reproductive
tissue specific promoter, the PrAGl promoter isolated from
Pinus radiata, and its use in promoting transcription/
expression of associated sequences in plant reproductive
tissue, including for the purpose of producing plants which
have diminished reproductive capacity or which are sterile.
30 Claims, 7 Drawing Sheets
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AAACTCGACAGCAAATATGATTTAGATTATGACCTAGAAATAAGCATAGCATTAAAGCAT 6 0
ATACATAACAAGCGGTGATATACTCTGACTGCCACTGTACTTGAGGAAAGGTAGTGGACT 1 2 0
CTGCTCAGGTACATTAGTTTGGTAAGGTTGGCTTGGCTTCTGGGTAATATGAGAAGTAAA 1 8 0
GAAGTAAAAGGTATTTGACTCTAGTCAAGTACATTGGATTGCCTTTGTCGGGGCTTGGAT 2 4 0
GGCTTGGGTTCGTGTGAGAAGCCAACAATTTATAAGAAATATATAAAATAAAAAATAAAA 3 0 0
AAATTTAAGTGTTGGAAGTGAAAACGGTGGGGCAGAAATATACACAGAAGAGTACTTTAA 3 6 0
CAATGCGCAACCAAGGCAGATTCACAACTTGATTTCTGGACCTCGAATACGAGATAATGG 4 2 0
TGGTAAGAAATAAAGGAAGAGTGGAGTGCATTTGAAAATGAATGGAGAGCGCACAAAATG 4 8 0
GAGGACGAATAAATGAAATATAATGCAAGAGTGCATTTCCCTATTATTTCCAGAAATGTA 5 4 0
TATGTGGGGTCGGCATTCACATGGGCGTCGCATTCAGGGGGTGTCATAGCGGTCCTTTGA 6 0 0
TTGCAGTGTGGGAGTTGCAACATGTACCAACAAATCCATTCATCCCAAAACCTAAATTTA 6 6 0
TCCTCTCCATTACTATTACCTACACCTATACCTAGTAAATATGTCCTGCCTTGTAACTCC 7 2 0
TCCACTGCCTGCACACGTCTTAGTCAATCCATCTGCCTTCAAATAGGCATTATTTTGTTC 7 8 0
TTTCCCCTCCGACTGAAAGGCTATCGACCGACCGACCGCTCATCTTCTTCTTCTGCGCAA 8 4 0
TTTTTTCTGCTGGATCATCATCATTACCATCATCGCCATCCCCACCATCATCATCATGAT 9 0 0
GGTATCTCTATCTCTCCCTGGCAATCGATTGTAGAGGAAAGGAAGAGGGAAGGGGCATAT 9 6 0
GTATTGATCAACCTACCCGAAAAAACAATCTGATCAGCCCTGCTCAATCTTGCTTATAAA 1 0 2 0
TCTCTTATCCACTGTTCAATCATTCAGGTTTCTTCCCACTTTCAAGCAAAGGCGCCCGGA 1 0 8 0
TTGGCCGTGTTCTTAGATTTTCAGGTACTTAAATGGACAATATTCCCCACCTGAAGCCGT 1 1 4 0
TCTGAAAAAGATTTGTTTGTAGAAACAAACGATTGTAATATTTGCTTAAGTTGAGCTTAA 1 2 0 0
GGGGTTTGGTACCTAACTTGCCTTGTGGTTATTTGTTTCTCAGAACTCGGGCTGCGTCCA 1 2 6 0
ACTGTAGGAACGAACCAGCACAAGGGGTTGCAGCTTTTGCTGTTGCTGTTGCGCCCATTG 1 3 2 0
CTTTTGGACTGGTATTAGTAGTTGCAGCTTTGTTTTGCATACGCTGTGAGGATCTGTGCG 1 3 80
CGGAAATTTTGTGTACAAATC
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PLANTS HAVING MODIFIED
REPRODUCTIVE CAPACITY

ductive tissue of a plant, causes said plant’s reproductive
organs to abort, to redefine themselves as vegetative, or to
stop development.
In still another embodiment, the open reading frame
polynucleotide encodes a peptide which, when expressed in
the reproductive tissue of a plant, causes cell death.
In yet another embodiment, the open reading frame poly
nucleotide encodes a peptide, which when expressed in
reproductive tissue of a flowering plant, causes an alteration
in the timing of flowering of said plant.
In a preferred form, the construct further includes:
(d) a selection marker sequence.
In a further aspect, the invention provides a transgenic
plant cell which includes a construct as described above.
By “transgenic” as used herein, the applicants mean
containing non-endogenous genetic material.
In another aspect, the invention provides a transgenic
plant which includes a construct as described above.
In still another aspect, the invention provides a transgenic
plant which contains a polynucleotide having activity as a
transcriptional promoter as described above or a reproduc
tive tissue promoter as described above, which plant has a
reduced reproductive capacity.
It is particularly preferred that the plant be sterile.
Conveniently, in said plant said polynucleotide or pro
moter is operatively associated with a nucleotide sequence
encoding a RNAse.
The plant can be a coniferous plant, such as a coniferous
plant of the Firms genus, or a tree such as a member of the
Eucalyptus genus.
It is particularly preferred that the transgenic plant be a
member of a species selected from Firms radiata, Firms
taeda, Firms elliotti, Firms cause, Firms palustrus, Firms
echinata, Firms ponderosa, Firms Jeffrey, Firms resinosa,
Pinus rigida, Firms banksiana, Pinus serotina, Firms
strobus, Pinus monticola, Pinus lambertiana, Pinus
virginiana, Pinus contorta, Pinus cariboea, Pinus pinaster,
Pinus brutia, Pinus eldarica, Pinus coulteri, Pinus nigra,
Pinus sylvestris, Pinus tecunumannii, Pinus keysia, Pinus
oocarpa and Pinus maxinumoii.

This application was filed under 35 U.S.C. 371, based on
PCT/NZ00/00031, which application was filed Mar. 17,
2000 and claims priority from New Zealand Application No.
334715, filed March 17; 1999.
This invention relates to plants having modified repro
ductive capacity. In particular, it relates to a plant reproduc
tive tissue specific promoter and its use in promoting
transcription/expression of associated genes in plant repro
ductive tissue, including for the purpose of producing plants
which have diminished reproductive capacity or which are
sterile.
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INTRODUCTION
It is desirable that the genetic basis of reproduction/flower
development in plants be determined. Identification of genes
involved in plant reproduction and/or flower development
together with the regulatory elements which control their
expression in reproductive tissue allows for modulation of
the reproductive capacity of plants and specifically enables
the production of reproductively null (sterile) plants.
Identification of the regulatory elements involved further
allows for the expression in reproductive tissue of genes
which are heterologous to the plant where that is desirable.
The applicants have now identified and isolated such a
reproductive tissue specific promoter which endogenously
regulates expression of a peptide involved in the reproduc
tive cycle of Firms radiata. It is broadly towards this
promoter, to its homologs in other plants and to its use in
effecting expression of associated genes within the repro
ductive tissue of plants that the present invention is directed.
SUMMARY OP THE INVENTION
In a first aspect, the present invention provides a poly
nucleotide which has a nucleotide sequence of from nucle
otides 1 to 1320 of FIG. 2 and which has the ability, when
operatively associated with a nucleotide sequence encoding
a peptide, to promote transcription of that nucleotide
sequence, or a polynucleotide which is a functionally
equivalent variant thereof.
In a second aspect, the invention provides a plant repro
ductive tissue promoter which has a nucleotide sequence of
from nucleotides 1 to 1320 of FIG. 2, or a functionally
equivalent variant thereof.
In a further aspect, the invention provides a DNA con
struct which comprises:
(a) a polynucleotide having activity as a transcriptional
promoter as described above;
(b) an open reading frame polynucleotide coding for a
peptide; and
(c) a termination sequence.
In yet a further aspect, the invention provides a DNA
construct which comprises:
(a) a promoter sequence as defined above;
(b) an open reading frame polynucleotide coding for a
peptide; and
(c) a termination sequence.
In each construct the open reading frame can be in a sense
orientation, or an anti-sense orientation.
In one embodiment, the open reading frame polynucle
otide encodes a peptide having the sequence of FIG. 1.
In other embodiments, the open reading frame polynucle
otide encodes a peptide which, when expressed in repro
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While the invention is broadly as defined above, it will be
appreciated by those persons skilled in the art that it is not
limited thereto and that it further includes embodiments of
which the following description provides examples. In
addition, the invention will be better understood through
reference to the accompanying drawings in which:
FIG. 1 shows the amino acid sequence (SEQ ID NO:4) of
the reproductive peptide PrAGl, together with the nucle
otide sequence coding therefor (SEQ ID NO:3):
FIG. 2 shows the sequence of the PrAGl promoter, which
is the focus of the present invention, isolated from Pinus
radiata (SEQ ID NO:2):
FIG. 3 is an RNA gel blot analysis of PrAGl mRNA
accumulation in Pinus radiata organs. Twenty fig of total
RNA from various organs was electrophoresed, blotted onto
nylon membranes, and hybridized with 3'-terminal fragment
of PrAGl cDNA. Total RNA was isolated from immature
male cone (M), immature female cone (F), vegetative shoot
(V)s, needle (N) and stem (S). The 26S and 18S rRNA was
used as control (bottom);
FIG. 4 is a DNA gel blot analysis of Pinus radiata
genomic DNA hybridized with the 3' terminal region of
PrAGl. 20 fig genomic DNA was digested with BamHI
(BA) and Bgl II (BG) EcoRI (E), Hindlll (H), Xhol (X);

US 6,858,776 B1
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FIG. 5 is a Reverse Transcription-Polymerase Chain
tion. The use of the BLAST family of algorithms, including
BLASTN, is described at NCBI’s website at URL http://
Reaction (RT-PCR) analysis showing reproductive-organ
www.ncbi.nlm.nih.gov/BLAST/newblast.html. The com
specific expression of PrAGl. RT-PCR analysis was per
puter algorithm FASTA is available on the Internet at the ftp
formed on total RNA isolated from different organs of
radiata Pine: (M) immature male cone, (F) immature female 5 site ftp://ftp.virginia.edu/pub/fasta/. Version 2.0 u4, Febru
ary 1996, set to the default parameters described in the
cone, (Vs) vegetative shoot, (N) needle and (S) stem. MADS
documentation and distributed with the algorithm, is also
box genes were amplified with PrAGl gene-specific oligo
preferred for use in the determination of variants according
nucleotides. Products from the PCR reactions were
to the present invention. The use of the FASTA algorithm is
electrophoresed, blotted, and hybridized with a labelled
probe of PrAGl specific fragment; from the PCR reactions 10 described in W. R. Pearson and D. J. Lipman, “Improved
Tools for Biological Sequence Analysis”, Proc. Natl. Acad.
were electrophoresed, blotted, and hybridized with a
Sci. USA 85:2444-2448 (1988).
labelled probe of PrAGl specific fragment;
The following running parameters are preferred for deter
FIG. 6 shows the construction of pRAGPR;
mination of alignments and similarities using BLASTN that
FIG. 7. PCR analysis of transgenic tobacco lines.
Genomic DNA (200 ng each) from controls and putative 15 contribute to E values (as discussed below) and percentage
identity Unix running command: blastall -p blastn -d embldb
transgenic tobacco plants was used as template along with
-e 10-G 1-E 1-r 2-v 50-b 50-1 queryseq -o results; and
primers for NPTII gene. Lane PC is positive control (20 ng
parameter default values:
pRAGPR plasmid was used as a template); C1-C3 are
-p Program Name [String]
control nontransformed tobacco plants; lanes la, lb , 2, 3a,
3b, 3c, 4a, 4b are transgenic plants. The size of NPTII gene 20 -d Database [String]
-e Expectation value (E) [Real]
PCR product is indicated on the right;
-G Cost to open a gap (zero invokes default behaviour)
FIG. 8 . Southern analysis of transgenic and control
[Integer]
tobacco lines to confirm integration of PrAGl promoter-E Cost to extend a cap (zero invokes default behaviour)
RNAse gene cassette. Genomic DNA (20 ug each) was
25
[Integer]
digested with Hind III and Sac I enzymes, electrophoresed
-r Reward for a nucleotide match (blastn only) [Integer]
and transferred to a nylon membrane. 32-p labeled RNAse
-v Number of one-line descriptions (V) [Integer]
gene was used as a probe. The size of PrAGl promoter-b Number of alignments to show (B) [Integer]
RNAse gene cassette is indicated on the right. Designation
-i Query File [File In]
of control and transgenic plants is as indicated in FIG. 7; and
30 -o BLAST report Output File [File Out] Optional
FIG. 9. Southern analysis of transgenic and control
The “hits” to one or more database sequences by a queried
tobacco lines to confirm integration profiles of PrAGl
sequence produced by BLASTN, FASTA, or a similar
promoter-RNAse gene cassette. Genomic DNA(20 ug each)
algorithm, align and identify similar portions of sequences.
was digested with Hind III enzyme, electrophoresed and
The hits are arranged in order of the degree of similarity and
transferred to a nylon membrane. 32-P labeled RNAse gene 35 the length of sequence overlap. Hits to a database sequence
was used as a probe. Sizes of DNA fragments hybridizing to
generally represent an overlap over only a fraction of the
the RNAse gene probe are indicated on the right. Designa
sequence length of the queried sequence.
tion of control and transgenic plants is as indicated in FIG.
The BLASTN and FASTA algorithms also produce
7.
“Expect” or E values for alignments. The E value indicates
40 the number of hits one can “expect” to see over a certain
DESCRIPTION OF THE INVENTION
number of contiguous sequences by chance when searching
As broadly outlined above, the applicants have identified
a database of a certain size. The Expect value is used as a
a plant promoter which is involved in plant reproduction.
significance threshold for determining whether the hit to a
The promoter, which was isolated from Pinus radiata is
database, such as the preferred EMBL database, indicates
called herein the “PrAGl promoter”.
45 true similarity. For example, an E value of 0.1 assigned to a
The nucleotide sequence of the PrAGl promoter is given
hit is interpreted as meaning that in a database of the size of
in FIG. 2 from nucleotides 1 to 1320. It will however be
the EMBL database, one might expect to see 0.1 matches
appreciated that the invention is not restricted only to the
over the aligned portion of the sequence with a similar score
polynucleotide having that specific nucleotide sequence.
simply by chance. By this criterion, the aligned and matched
Instead, the invention also extends to functionally equivalent 50 portions of the sequences then have a 90% probability of
variants of that polynucleotide.
being the same. For sequences having an E value of 0.01 or
The phrase “functionally equivalent variants” recognises
less over aligned and matched portions, the probability of
that it is possible to vary nucleotide sequence while retaining
finding a match by chance in the EMBL database is 1% or
substantially equivalent functionality. Variants can have a
less using the BLASTN or FASTA algorithm.
greater or lesser degree of homology as between the variant 55
It is also recognised that as the function of the polynucle
nucleotide sequence and the original.
otide is as a transcriptional promoter there are regions of the
polynucleotide which are more critical to, and characteristic
Polynucleotide sequences may be aligned, and percentage
of, this function than others. An example are the TATA boxes
of identical nucleotides in a specified region may be deter
at positions 280 to 286, 282 to 288 and 1015 to 1021 from
mined against another sequence, using computer algorithms
that are publicly available. Two exemplary algorithms for 60 the 5' end of the sequence. Therefore, polynucleotides which
include these regions of the polynucleotide of FIG. 2 and
aligning and identifying the similarity of polynucleotide
have equivalent transcriptional functionality are contem
sequences are the BLASTN and FASTA algorithms. The
plated variants, even where there is a lesser degree of
BLASTN software are available on the NCBI anonymous
homology elsewhere in the sequence.
FTP server (ftp ://n c b i.n lm .n ih .g o v ) under /b la st/
executables/. The BLASTN algorithm version 2.0.4 [Feb. 65
According to one embodiment, “variant” polynucleotides,
24, 1998], set to the default parameters described in the
with reference to the polynucleotide of the present
documentation of variants according to the present inven
invention, preferably comprise sequences having the same

US 6,858,776 B1
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number or fewer nucleic acids than the polynucleotide of the
The expression/transcription product can be a relatively
present invention and producing an E value of 0.01 or less
small molecule and still be capable of disrupting mRNA
when compared to the polynucleotide of the present inven
translation. However, the same result is achieved by express
tion. That is, a variant polynucleotide is any sequence that
ing the target gene in an anti-sense orientation such that the
has at least a 99% probability of being the same as the 5 RNA produced by transcription of the anti-sense oriented
polynucleotide of the present invention, measured as having
gene is complementary to all or part of the endogenous
an E value of 0.01 or less using the BLASTN or FASTA
target mRNA.
algorithms set at the parameters discussed above.
Such anti-sense strategies are described generally by
Robinson-Benion et al., (1995), Anti-sense techniques,
Variant polynucleotide sequences will also generally
hybridize to the recited polynucleotide sequence under strin 10 Methods in Enzymol. 254(23):363-375 and Kawasaki et al.,
(1996), Artific. Organs 20 (8): 836-848.
gent conditions. As used herein, “stringent conditions” refers
to prewashing in a solution of 6xSSC, 0.2% SDS; hybrid
Dominant negative approaches involve using the PrAGl
izing at 65° C., 6xSSC, 0.2% SDS overnight; followed by
promoter to effect the expression of a modified DNA
two washes of 30 minutes each in lxSSC, 0.1% SDS at 65°
binding/activating protein which includes a DNA binding
C. and two washes of 30 minutes each in 0.2xSSC, 0.1% 15 domain but not a activator domain. The result is that the
SDS at 65° C.
protein binds to DNA as intended but fails to activate, while
at the same time blocking the binding of the DNA binding/
It is of course expressly contemplated that homologs to
activating peptides which normally bind to the same site.
the PrAGl promoter exist in other plants, particularly other
coniferous plants, including other members of the Pinus
It is however presently preferred that the reproductive
genus. Such homologs are also “functionally equivalent 20 capacity of the plant be reduced or eliminated through the
variants” of PrAGl promoter as the phrase is used herein.
use of the PrAGl promoter to drive transcription and
DNA sequences from plants other than Pinus radiata
expression of a nucleotide sequence which encodes an
which are homologs of the PrAGl promoter may be isolated
RNAse within the plant reproductive tissue. Such an
by high throughput sequencing of cDNA libraries prepared
approach, in which the PrAGl promoter is coupled to the
from such plants. Alternatively, oligonucleotide probes 25 RNAse, RNS2, is exemplified herein.
based on the sequence for the PrAGl promoter provided in
To give effect to the above strategies, the invention also
FIG. 2 can be synthesized and used to identify positive
provides DNA constructs. The constructs include the PrAGl
clones in either cDNA or genomic DNA libraries from other
promoter sequence, the DNA intended to be transcribed/
plants by means of hybridization or PCR techniques. Probes
expressed (such as the PrAGl gene in sense or in anti-sense
should be at least about 10, preferably at least about 15 and 30 orientation or a polynucleotide encoding an RNAse) and a
most preferably at least about 20 nucleotides in length.
termination sequence, operably linked to the DNA sequence
Elybridization and PCR techniques suitable for use with such
to be transcribed. The promoter sequence is generally posi
ligonucleotide probes are well known in the art. Positive
tioned at the 5' end of the DNA sequence to be transcribed,
clones may be analyzed by restriction enzyme digestion,
and is employed to initiate transcription of the DNA
DNA sequencing or the like.
35 sequence.
The polynucleotides of the present invention may be
The DNA with which the PrAGl promoter is operatively
generated by synthetic means using techniques well known
associated can encode any peptide it is desirable to express
in the art. Equipment for automated synthesis of oligonucle
in plant reproductive tissue. As indicated above, this
otides is commercially available from suppliers such as
includes the peptide encoded by PrAGl, but can also be
Perkin Elmer/Applied Biosystems Division (Foster City, 40 another peptide. That other peptide can be a peptide which,
Calif.) and may be operated according to the manufacturer’s
when produced, causes the reproductive organs of the plant
instructions.
to abort, redefine themselves as vegetative or stop develop
ment. The peptide encoded can, for example, also be a
The P rA G l prom oter of the invention is plant
peptide causing cell death. Illustrative peptides/genes are
reproductive-tissue-specific. The primary importance of
identification of the polynucleotide of the invention is there 45 Diphtheria Toxin A (DTA), Barnase (from Bacillus
am yloliquefaciens), apoptosis genes, glucanase, and
fore that it enables the reproductive capacity of plants to be
RNAses, with the selection of each being a matter of choice
modulated. This modulation will generally involve a reduc
for the art skilled worker.
tion in the reproductive capacity of the plant.
Any conventional technique for effecting this can be
Alternatively, the peptide which is to be expressed under
employed. Examples include co-suppression or anti-sense 50 the control of the PrAGl promoter can be one which, when
produced, alters the timing of flowering (ie. either delays or
strategies, a dominant negative approach, or techniques
accelerates flowering, such as the ELF-3 and CONSTANS
which involve expressing enzymes (such as RNAses) to
flowering time genes).
digest, or otherwise be lethal to, RNA post-transcription of
a target gene.
The peptide to be expressed can be ligated to the promoter
Co-suppression can be effected in a manner similar to that 55 in a sense or antisense orientation, dependant upon the
discussed, for example, by Napoli et al (Plant Cell
desired effect.
2:279-290, 1990) and de Carvalho Niebel et al (Plant Cell
The termination sequence, which is located 3' to the DNA
sequence to be transcribed, may come from the same gene
7:347-258, 1995). In some cases, it can involve overexpres
sion of the gene of interest through use of multiple con
as the PrAGl promoter or may be from a different gene.
structs of the PrAGl promoter and gene to be suppressed. 60 Many termination sequences known in the art may be
usefully employed in the present invention, such as the 3'
Anti-sense strategies involve using the PrAGl promoter
end of the Agrobacterium tumefaciens nopaline synthase
to effect expression or transcription of DNA with the
gene. However, preferred termination sequences are those
expression/transcription product being capable of interfering
from the original gene or from the target species to be
with translation of mRNA transcribed from the gene to be
suppressed. This will normally be through the expression/ 65 transformed.
transcription product hybridising to and forming a duplex
The DNA constructs of the present invention may also
with the target mRNA.
contain a selection marker that is effective in plant cells, to
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allow for the detection of transformed cells containing the
Eucalyptus robusta, Eucalyptus rudis, Eucalyptus saligna,
Eucalyptus sideroxylon, Eucalyptus stuartiana, Eucalyptus
construct. Such markers, which are well known in the art,
tereticornis, Eucalyptus torelliana, Eucalyptus urnigera,
typically confer resistance to one or more toxins. One
Eucalyptus urophylla, Eucalyptus viminalis, Eucalyptus
example of such a marker is the NPTII gene whose expres
sion results in resistance to kanamycin or hygromycin, 5 viridis, Eucalyptus wandoo and Eucalyptus youmanni; and
hybrids between any of the above species.
antibiotics which are usually toxic to plant cells at a mod
As discussed above, transformation of a plant with a DNA
erate concentration (Rogers et al., in Methods for Plant
construct
including an open reading frame coding for a
Molecular Biology, A Weissbach and H Weissbach eds,
peptide wherein the open reading frame is orientated in a
Academic Press Inc., San Diego, Calif. (1988)). Other
sense direction can, in some cases, lead to a decrease in
examples of markers include visible selection markers such 10
expression of the peptide by co-suppression. Transformation
as Green Fluorescent Protein (GFP) and herbicide resistance
of the plant with a DNA construct comprising an open
genes. Alternatively, the presence of the desired construct in
reading frame in an anti-sense orientation or a non-coding
transformed cells can be determined without reference to
(untranslated) region of a gene will lead to a decrease in the
marker genes, by means of other techniques well known in
expression of the peptide in the transformed plant.
the art, such as Southern and Western blots.
15
Techniques for stably incorporating DNA constructs into
Techniques for operatively linking the components of the
the genome of target plants are well known in the art and
DNA constructs are well known in the art and include the
include Agrobacterium tumefaciens mediated introduction,
use of synthetic linkers containing one or more restriction
electroporation, protoplast fusion, injection into reproduc
endonuclease sites as described, for example, by Maniatis et
tive organs, injection into immature embryos, high velocity
al., (Molecular Cloning: A Laboratory Manual, Cold Spring 20
projectile introduction and the like. The choice of technique
Flarbour Laboratories, Cold Spring Flarbour, N.Y., 1989).
will depend upon the target plant to be transformed.
The DNA construct may be linked to a vector having at least
Once the cells are transformed, cells having the DNA
one replication system, for example, E. coli, whereby after
construct incorporated into their genome may be selected by
each manipulation, the resulting construct can be cloned and
means of a marker, such as the NPT II or kanamycin
sequenced and the correctness of the manipulation deter 25
resistance markers discussed above. Transgenic cells may
mined.
then be cultured in an appropriate medium to regenerate
The DNA constructs of the present invention may be used
whole plants, using techniques well known in the art. In the
to transform a variety of plants. In one embodiment, these
case of protoplasts, the cell wall is allowed to reform under
will be plants of the Pinus genus. In a preferred embodiment,
appropriate osmotic conditions. In the case of seeds or
the DNA constructs are employed to transform Pinus 30
embryos, an appropriate germination or callus initation
radiata, Pinus taeda, Pinus elliotti, Pinus clausa, Pinus
medium is employed. For explants, an appropriate regen
palustrus, Pinus echinata, Pinus ponderosa, Pinus Jeffrey,
eration medium is used.
Pinus resinosa, Pinus rigida, Pinus banksiana, Pinus
For a review of regeneration of forest trees such as those
serotina, P in u s strobus, P in u s m onticola , P in u s
of the Pinus genus, see Dunstan et al., Somatic embryogenlambertiana, Pinus virginiana, Pinus contorta, Pinus 35
esis in woody plants. In: Thorpe, T. A. ed. 1995: in vitro
cariboea, Pinus pinaster, Pinus brutia, Pinus eldarica,
embryogenesis of plants. Vol 20 in Current Plant Science
Pinus coulteri, Pinus nigra, Pinus sylvestris, Pinus
and Biotechnology in Agriculture, Chapter 12, pp. 471-540.
tecunumannii, Pinus keysia, Pinus oocarpa and Pinus
The promoter, and constructs containing it, are not
maxinumoii, and hybrids between the above species.
restricted in use to plants of forestry species. They can also
The constructs can also be used to transform other plants 40
be used to transform other agronomically important plants in
such as trees selected from Abies amabilis, Abies balsamea,
which modulation of reproductive capacity (particularly the
Abies concolor, Abies grandis, Abies lasiocarpa, Abies
timing and abundance of flowering) is desirable. Such plants
magnifica, Abies procera, Chamaecyparis lawsoniona,
include cereals, rice, maize, wheat, barley, oats, rye, soya
Chamaecyparis nootkatensis, Chamaecyparis thyoides,
bean and canola.
Huniperus virginiana, Larix decidua, Larix laricina, Larix 45
The resulting transformed plants may be reproduced
leptolepis, Larix occidentalis, Larix siberica, Libocedrus
sexually or asexually, using methods well known in the art,
decurrens, Picea abies, Picea engelmanni, Picea glauca,
to give successive generations of transgenic plants.
Picea mariana, Picea pungens, Picea rubens, Picea
The invention will now be described with reference to the
sitchensis, Pseudotsuga menziesii, Sequoia gigantea,
following non-limiting examples.
Sequoiasem pervirens, Taxodium distichum , Tsuga 50
canadensis, Tsuga heterophylla, Tsuga mertensiana, Thuja
EXPERIMENTAL
occidentalis, Thuja plicata; Eucalypts, such as Eucalyptus
Section 1
alba, Eucalyptus bancroftii, Eucalyptus botyroides, Euca
1. PrAGl cDNA Cloning:
lyptus bridgesiana, Eucalyptus calophylla, Eucalyptus
Total RNA was purified from immature cone of radiata
cam aldulensis, E u ca lyp tu s citriodora, E u ca lyp tu s 55 pine according to the protocol of Charles Ainsworth (Plant
cladocalyx, Eucalyptus coccifera, Eucalyptus curtisii, Euca
Molecular Biology Reporter, 12(3), 1994: 198-203). The
lyptus dalrympleana, Eucalyptus deglupta, Eucalyptus
mRNA was isolated with oligo-T cellulose column. With
delagatensis, Eucalyptus diversicolor, Eucalyptus dunnii,
mRNA as template, the cDNA was synthesised with CapEucalyptus ficifolia, Eucalyptus globulus, Eucalyptus
Finder cDNA synthesis kit (ClonTech Co.). The cDNA was
gomphocephala, Eucalyptus gunnii, Eucalyptus henryi, 60 inserted into Lambda TriplEx Vector (ClonTech Co.), then
Eucalyptus laevopinea, Eucalyptus macarthurii, Eucalyptus
packaged it with Gigapack@ III packaging extracts
m acrorhyncha, E u c a ly p tu s m aculata, E u ca lyp tu s
(Stratagene Co.) to obtain a cDNA library.
marginata, Eucalyptus megacarpa, Eucalyptus melliodora,
Two degenerate primers were designed:
E ucalyptus nicholii, E ucalyptus nitens, Eucalyptus
3' PCR primer: 5' GCIGTIAGIYCITCICCCAT 3'; (SEQ ID
novaanglica, Eucalyptus obliqua, Eucalyptus obtusiflora, 65
NO: 7)
Eucalyptus oreades, Eucalyptus pauciflora, Eucalyptus
5' PCR primer: 5' AAYCGICARGTIACITT 3' (SEQ ID
polybractea, Eucalyptus regnans, Eucalyptus resinifera,
NO: 8)
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These primers were used to perform RT-PCR based
differential screening on RNA from various female tissue
sources, including immature female buds, vegetative tissue
from needles and later stages of development. The 50-ul
reaction mixture contained 2.5 Units Taq DNA polymerase, 5
fx Polymerization Buffer (both from ClonTech Co.), f
mMMgCl2, 0.2 mMdNTP and 0.25 uM primers. The PCR
was performed under the following conditions: denaturation
at 94° C. for 30 s, annealing at 50° C. for f min and
extension at 72° C. for f min for 30 cycles on a Thermal 10
Cycler 480 (Perkin-Elmer, Norwalk, Conn., USA).
Fragments were obtained mostly from immature female
bud tissue RNA samples. Several DNA fragments were
cloned into pGEM-T vector and sequenced. Sequence analy
sis showed that most of these fragments contained similar 15
sequences. One of the DNA fragments (309 bp) was chosen.
This was used as a probe to screen the cDNA library to clone
its full-length cDNA and resulted in the cDNA clone,
PrAGl. The sequence of PrAGl was analysed on both
strands by the Sanger’s dideoxy method (Sanger et al., 1977, 20
Proc. Natal. Acad. Sci. U.S.A. 74: using a Sequenase kit
(United States Biochemical co.).
The resulting sequence is shown in FIG. 1 gives the
nucleotide sequence coding for the peptide of the invention
together with the predicted amino acid sequence.
25
Sequence comparison and phylogenetic analysis were
conducted with the software program MacDNASIS (Version
3.5, Hitachi Corp.). The results of analysis revealed PrAGl
to be a MADS box gene.
2. PrAGl Promoter Cloning:
30
I. Genomic DNA Purification:
Genomic DNA was purified from young needles accord
ing to a CTAB method as described below.
1) 2 g of young needles of Pinus radiata were ground in
35
liquid nitrogen (mortar and pestle) to a fine powder.
2) This powder was mixed with 15 mL of pre-warmed
CTAB extraction buffer [3% CTAB (W/V), 100 mM TrisHC1 pH8.0, 20 mM EDTA pH8.0, 1.4 M NaCl, 1% PVP
940,000, 1% beta mercaptoethanol] and incubated at 65° C.
for one hour.
40
3) To the above mixture 15 mL chloroform was added and
mixed gently.
4) The contents were centrifuged at 10,000 g for 20
minutes at 4° C.
5) The supernatant was transferred to a new tube, and 45
mixed with Vio volume of 3M sodium acetate (pH4.8), and
0.7 volume of isopropanol. The DNA was precipitated at
-20° C. for 30 minutes.
6) The DNA was pelleted at 10,000 g for 10 minutes at 4°
C.
50
7) The DNA pellet was then air dried and resuspended in
2 mL TE buffer (10 mM Tris-HCl pH7.5, 1 mM EDTA
pH8.0) and 2,&1 of RNAse A (10 fig/fiV) was added. The
contents were incubated at 37° C. for 30 minutes to remove
any RNA from the sample.
55
8) After the incubation, 2 mL of 5M Ammonium acetate
and 10 mL of 100% ethanol were added and the contents
kept at -20° C. for 15 minutes.
9) The mixture was then centrifuged at 10,000 g for 10
minutes at 4° C. to pellet DNA. The DNApellet was washed 60
in 70% ethanol twice.
10) The DNA pellet was air dried and resuspended in 200
uL TE bufffer.
II. Cloning of PrAGl Promoter with Two Step Genomic
DNA Walking.
65
1)
The Universal Genome Walker Kit (CLONTECH) was
employed. For the first step genomic DNA walking, two

10
PrAGl specific primers were designed and synthesized
according to the PrAGl cDNA sequence. The sequences of
the primers were:
Primer GSP1: 5°c CGC CTT CTT CAA TAA ACC ATT
TCG GCG CTT 3' (SEQ ID NO:9)
Primer GSP2: 5' GAC CTG TCG GTT COT AGT ATT TTC
AAT CCT 3' (SEQ ID NO: 10)
2) Based upon the promoter sequence we got from step 1),
two PrA G l promoter sequence specific primer were
designed and synthesized. The primers were:
Primer GSP3: 5' TTC GTC CTC CAT TTT GTG CGC TCT
CCA TTC 3' (SEQ ID N O :ll)
Primer GSP4: 5' GCA CTC CAC TCT TCC TTT ATT TCT
TAC CAC 3' (SEQ ID NO: 12)
3) According to the User Manual of Universal Genome
Walker Kit, 13 genome walker libraries were constructed
after genomic DNA digestion with restriction enzymes:
EcoR V, Sea I, Dra I, Pvu II, Ssp I, Stu I, Sma I, Hap I, BsaB
I, Bcll36 II, Pml I, Nru I, Hie II.
4) With 13 genome walker libraries as templates, and
adaptor primer 1 (API primer from kit) and GSP1 primer,
first round PCR was performed under the conditions sug
gested by the kit manufacturer. After agarose electrophoresis
analysis of the PCR product, second round PCR was per
formed with the nested primers AP2 (Adaptor primer from
the kit) and GSP2. The PCR products from the second round
PCR were purified and cloned into pGEM-T easy vector
(Promega). Following sequence analysis, and DNA
sequence comparison with PrAGl cDNA, one DNA frag
ment of 1105 bp from Sea I genome walker library was
obtained which was identified as the promoter region of
PrAGl, based upon the overlapped region between it and
PrAGl cDNA.
5) The second step genome walking was done with primer
pair A PI and GSP3, and primer pair AP2 and GSG4. A DNA
fragment of 449 bp from the Dra I genome walker library
was identified as the upstream sequence of the PrAGl
promoter cloned from the first step genome walking based
on the sequence comparison of overlapped region between
them.
6) The 1105 bp and 449 bp fragments were used in PCR
mediated DNA splicing to synthesize one continuous 1458
pb promoter fragment of PrA G l. This was done as
described. One primer was synthesized based on the 5'end
sequence of 1105 bp promoter fragment: Primer PLi, 5' AGT
TAC TTA ACA ATG CGC MC CAA GGC 3' (SEQ ID NO.
13). Primer pair PLi and GSP2 was used in PCR to get the
promoter fragment of 1105 pb, in which the AP2 primer
sequence was removed. This 1105 bp fragment and 449 bp
fragment was then added in one PCR tube as a template with
the primer pair of AP2 and GAP2 to do the second round
PCR to get the 1458 bp PCR fragment. The conditions of
second round PCR were as follows: the first cycle at 95° C.
for 5 minutes, and 68° C. for 10 min; the second cycle at 94°
C. for 30 seconds (DNA denaturing), DNA annealing at 60°
C. for 1 min, and DNA synthesis at 72° C. for 2 minutes; this
regime was cycled 30 times. This 1458 bp fragment was then
cloned into pGEM-T easy vector (Promega) and subjected to
DNA sequencing on both strands to confirm the DNA
sequence and to make sure that no base changes occurred
during the PCR process.
The sequence of the promoter, (which is the PrAGl
promoter), is given in FIG. 2 from nucleotides 1 to 1320.
7) DNA sequence analysis has indicated that compared to
its orthologs from other plants, the PrAGl showed that there
were two possible positions for transcription initiation: at
position 791 or 1326 in the FIG. 2 sequence. It was found
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three typical TATA boxes in the PrAGl promoter at the
(FIGS. 3 and 5). This tissue distribution profile, when
position of 280 to 286, 282 to 288, 1015 to 1021. Based on
combined with the fact that PrAGl contains a MADS box,
the start codon position and short 5' untranslated region in
verifies that PrAGl is a reproductive gene in Pinus radiata
and that the PrAGl promoter is reproductive-tissue specific.
the PrAGl cDNA, the transcription initiation point is iden
tified as position 1326 in the FIG. 2 sequence.
5
Southern blot analysis showed that PrAGl gene exists as
a single copy in the genome of Pinus radiata (FIG. 4).
3. DNA and RNA Gel Blot Hybridizations:
Section 2
Genomic DNA and RNA gel blots were made using
standard techniques (Sambrook et al., 1989. Molecular
Construction of Binary Vector pRAGPR, Plant Transforma
Cloning: A Laboratory Cold Spring Harbor, N.Y.: Cold
tion and Regeneration f Transgenic Tobacco Plants
Spring Harbor Laboratory Press).
10
A DNA fragment containing the PrAGl promoter (1.40
kb, SEQ ID NO:2) operably fused to an RNAse gene (0.95
RNA: Total RNA was prepared from needle, vegetative
kb, RNS2, Taylor et al. Proc Natl Acad Sci, USA 90 (11),
shoot, stem, immature female cone and immature male cone
5118-5122 (1993)) and containing Hind III and Sac I sites
samples as described above. Briefly, 20 fig of total RNA was
was gel purified and ligated into the Hind III/Sac I sites of
denatured in formaldehyde loading buffer and fractionated
by denaturing agarose gel electrophoresis on a formaldehyde 15 binary vector pRD420, containing the NPTII gene for plant
selection, (provided by Dr. R. S. S. Datla, PBI, Saskatoon,
containing gel. The agarose gel was stained with ethidium
Canada) resulting in the construct pRAGPR (FIG. 6). The
bromide and a picture taken as control. The RNA was then
construct was introduced into Agrobacterium tumefaciens
transferred to a nylon membrane by the capillary blotting
(strain c58 MP90), and used to transform and regenerate
method. The RNA was immobilised on the membrane by
UV cross-linking and was prehybridized at 65° C. for 2 20 Nicotiana tabacum var. Xanthi by the standard leaf disc
transformation ethod (Horsch et al. (1985), A simple and
hours prior to hybridization in 0.5M Na-phosphate, pH 7.2,
general method for transferring genes into plants. Science
7.5% SDS, 1 mM EDTA, 100 ug/mL salmon sperm DNA.
227,1229-1231). Control lines were also generated through
A DNA fragment of PrAGl 3' end region was labelled with
leaf disk method without the selection process. After kana32P_dCTP (Decaprime B kit, Ambion, Austin, Tex.), and
hybridised to the RNA blot overnight at 65° C. The blot was 25 mycin selection, the putative transgenic plantlets were
rooted in the rooting medium containing kanamycin and
washed twice in 40 mMNa-P04, 1% SDS and 1 mM EDTA
then moved to pots containing the Metromix 350 potting
for 30 minutes each at 65° C., and exposed to X-ray film
mix. Potted plants were maintained under controlled condi
with intensifying screens at 80° C.
tions in a growth chamber with 16 h photoperiod. The plants
DNA: Genomic DNA was prepared from needle tissue
with CTAB method. Twenty fig genomic DNA was digested 30 were grown through the full life cycle of the tobacco until
senescence and the flowering of the transgenic tobacco
by Bam HI, Bgl II, Eco RI, Hin III and Xba I respectively.
assessed relative to controls. Transgenic plants were iden
After agarose gel running, alkali blotting of DNA to Hybond
tified further by PCR with template of genomic DNA and
N membranes was performed as described by the manufac
Southern blot analysis to confirm the integration of
turer (Amersham). The probe hybridisation and washing
was as described for the RNA blotting analysis.
35 pRAGPR in transgenic tobacco plants.
The results are shown in FIGS. 3 and 4.
Polymerase Chain Reaction Amplification
4. RT-PCR:
To check the genomic DNA integration of pRAGPR in the
Analysis was performed on total RNA isolated from
transgenic tobacco plants, gene-specific primers for the
needle, stem, vegetative shoot, immature female cone and
NPTII gene were employed. The primers used were NPTIIimmature male cone samples as described above. RNA was 40 5' primer 5-GAACAAGAT GCATTG CAC GC-3' (SEQ ID
reverse-transcribed with MMLV reverse-transcriptase
NO: 16) and NPTII-3' primer 5'-GAAGAACTC GTC AAG
(Gibco BRL) according to the manufacturer’s instructions.
AAG GC-3' (SEQ ID NO: 17). Genomic DNA from each of
PCR was performed with two primers: 5'PCR primer (5'
the control lines and transgenic tobacco lines were isolated
TTGTGTACAAATCATGGG 3') (SEQ ID NO: 14) and
from the leaf tissue using the Qiagen DNAeasy kit as per
3'PCR primer (5'GTAAGCCCGTCACCCATC 3') SEQ ID 45 manufacturer’s instructions. PCR reactions (50-/d final
NO: 15). Verification of the specificity of the PCR reactions
volume) were performed using 5 fil of template DNA.
was achieved through the use of controls that included
Samples were heated to 95° C. for 4 minutes, followed by 35
amplification reaction with single primers, RNAse treatment
cycles of 95° C. for 45 seconds, 55° C. for 30 seconds, and
of template, and no template. In those reactions in which no
73° C. for 2 minutes, with a final extension step of 73° C. for
PCR product was detected, the quality of the RNA was 50 5 minutes in PTC100 thermal cycler (MJ Research). Ampli
tested by UV scanning and agarose gel electrophoresis.
fied DNA fragments were analyzed on a 0.8% agarose gel
ss-cDNA from the RT reaction was used as a template. The
and visualized by staining with ethidium bromide.
50-ul reaction mixture contained 2.5 U Taq DNA
DNA Gel Blot Hybridization
polymerase, lx Polymerization Buffer (both from ClonTech
To confirm the genomic integration of PrAGl promoterCo.), 1 mM MgCl2, 0.2 mM dNTP and 0.25 fiM primers. 55 RNAse gene cassette in transgenic plants and to determine
The PCR was performed under following conditions: denathe copy number, Southern analysis was performed. For
turation at 94° C. for 30 s, annealing at 55° C. for 1 min and
Southern analysis, genomic DNA (20 fig) was digested with
appropriate restriction endonucleases, separated by electro
extension at 72° C. for 1 min for 30 cycles on Thermal
Cycler 480 (Perkin-Elmer, Norwalk, Conn., USA). The PCR
phoresis in a 0.8% agarose gel. Two sets of Southerns were
products were subjected to electrophoresis in agarose gel 60 performed, one with digesting the genomic DNA with Hind
and hybridization as described above.
III and Sac I to drop the PrAGl-RNAse cassette and another
with Hind III digest alone to test for integration profiles.
The results are shown in FIG. 5.
Following depurination in 0.25 M HC1 and denaturation in
Discussion
0.5 M NaOH, 1.5 M NaCl, the DNA was blotted onto a
Northern blot hybridization and RT-PCR analysis showed
that PrAGl mRNAis accumulated specifically in the imma 65 nylon membrane. The RNAse gene-specific probe (which is
the whole RNAse gene) was radioactively labelled using a
ture female cone and immature male cone; there is no
random-primed DECAprime II DNA labeling kit (Ambion,
expression detected in needle, stem, and vegetative shoot
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Austin, Tex.). Filters were hybridized at 65° C. in a hybrid
Reproductive Sterility in Transgenic Tobacco Caused by
ization buffer containing 0.5 M N aP04 (pFI 7.5), 7.5% SDS,
pRAGPR.
and 1 mM EDTA. All filters were washed finally at 68° C.
All the controls and transgenic lines were allowed to
in 20 mM N aP04 (pFI 7.5), 1% SDS. Filters were then
senesce (approximately 3 months). The controls flowered
subjected to autoradiography.
5 normally whereas none of the transgenic tobacco containing
the pRAGPR construct flowered. The plants with single
Results and Conclusions
copy PrAGl-RNAse cassette grew at the same rate as
Transgenic Tobacco Plants Expressing PrAGl Promoter
controls and senesced at the same time. The transgenic
Controlled RNAs Gene.
plants with two copies of pRAGPR were slower to grow, and
Eight independent transgenic lines of tobacco (N . tobaccum var Xanthi) with the PrAGl-RNAse fusion construct to matured late (#la, lb and 2).
were obtained together with three control lines processed
All transgenic plants eventually died and none flowered.
through the same tissue culture propagation method but
Another phenotypic change observed was in transgenic
without the selection. PCR was done on the putative trans
line #2, which developed additional lateral branches near the
genic plantlets, after rooting in selection medium, to confirm
top. This may be due to the lack of or decreased apical
the integration of the NPTII gene. All the eight lines were 15 dominance in these plants. Thus, the inhibition of flowering
positive for the NPTII gene and the controls were negative
using the PrAGl-RNAse cassette may have an added benefit
(FIG. 7). The transgenic plants were propagated in pots
to increase the biomass of the plant through increased
along with the controls.
branching if the growing conditions are not limiting.
Southern analysis was done on the eight transgenic lines
Industrial Application
and the three controls to confirm the integration and profiles 20
of integration of PrAGl promoter-RNAse gene cassette.
In its primary aspect, the invention provides a new,
Double digestion with Hind III and Sac I followed by
reproductive-tissue-specific promoter. This promoter can be
probing with RNAse gene probe indicated that all the eight
used in transforming a wide variety of plants. The promoter
transgenic plants had the PrAGl-RNAse cassette (FIG. 8).
can also be used to drive expression of any gene which it is
The single digest with Hind III indicated that 5 of the 25
desirable to express in plant reproductive organs, including
transgenic lines had single integration and three others had
flowering time genes.
two copies of the cassette.
The invention also has application in modulating, and in
Out of the 5 transgenic plants with single integration two
particular reducing or eliminating reproductive capacity in
profiles were found based on molecular weight size bands
that hybridized to the RNAse probe. Three plants had the 30 plants including those of the Pinus genus and Eucalyptus
genus. Such plants have utility in forestry.
same size band hybridizing at -4 kb (#s 3a, 3 c, 4a) whereas,
The availability of reproductively null or sterile pine or
the two other plants had a band hybridizing at -3 kb range
eucalyptus trees has the additional advantage that it will be
(#s 3b, 4b)(FIG. 9).
possible to introduce further exogenous genetic material into
Of the three transgenic plants that had two copies of the
cassette, two had same profile with a band at 5-6 kb and 35 those trees without the risk that the material will be passed
on to other trees.
another at 4 kb hybridizing to the RNAse probe (#la, lb),
whereas the other had two bands, one at 8 kb and another at
Those persons skilled in the art will appreciate that the
4 kb that hybridized to RNAse probe (#2) (FIG. 9).
specific description provided is exemplary only, and that
modifications and variations may be made without departing
All the three controls were negative for hybridization with
from the scope of the invention.
the RNAse probe (FIG. 8 and FIG. 9).

SEQUENCE LISTING

<160> NUMBER OF SEQ ID NOS: 17
<210>
<211>
<212>
<213>

SEQ ID NO 1
LENGTH: 1320
TYPE: DNA
ORGANISM: Pinus radiata

<400> SEQUENCE: 1
aaactcgaca gcaaatatga tttagattat gacctagaaa taagcatagc attaaagcat

60

atacataaca agcggtgata tactctgact gccactgtac ttgaggaaag gtagtggact

120

ctgctcaggt acattagttt ggtaaggttg gcttggcttc tgggtaatat gagaagtaaa

180

gaagtaaaag gtatttgact ctagtcaagt acattggatt gcctttgtcg gggcttggat

240

ggcttgggtt cgtgtgagaa gccaacaatt tataagaaat atataaaata aaaaataaaa

300

aaatttaagt gttggaagtg aaaacggtgg ggcagaaata tacacagaag agtactttaa

360

caatgcgcaa ccaaggcaga ttcacaactt gatttctgga cctcgaatac gagataatgg

420

tggtaagaaa taaaggaaga gtggagtgca tttgaaaatg aatggagagc gcacaaaatg

480
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16
-continued

gaggacgaat aaatgaaata taatgcaaga gtgcatttcc ctattatttc cagaaatgta

540

tatgtggggt cggcattcac atgggcgtcg cattcagggg gtgtcatagc ggtcctttga

600

ttgcagtgtg ggagttgcaa catgtaccaa caaatccatt catcccaaaa cctaaattta

660

tcctctccat tactattacc tacacctata cctagtaaat atgtcctgcc ttgtaactcc

720

tccactgcct gcacacgtct tagtcaatcc atctgccttc aaataggcat tattttgttc

780

tttcccctcc gactgaaagg ctatcgaccg accgaccgct catcttcttc ttctgcgcaa

840

ttttttctgc tggatcatca tcattaccat catcgccatc cccaccatca tcatcatgat

900

ggtatctcta tctctccctg gcaatcgatt gtagaggaaa ggaagaggga aggggcatat

960

gtattgatca acctacccga aaaaacaatc tgatcagccc tgctcaatct tgcttataaa

1020

tctcttatcc actgttcaat cattcaggtt tcttcccact ttcaagcaaa ggcgcccgga

1080

ttggccgtgt tcttagattt tcaggtactt aaatggacaa tattccccac ctgaagccgt

1140

tctgaaaaag atttgtttgt agaaacaaac gattgtaata tttgcttaag ttgagcttaa

1200

ggggtttggt acctaacttg ccttgtggtt atttgtttct cagaactcgg gctgcgtcca

1260

actgtaggaa cgaaccagca caaggggttg cagcttttgc tgttgctgtt gcgcccattg

1320

<210>
<211>
<212>
<213>

SEQ ID NO 2
LENGTH: 1401
TYPE: DNA
ORGANISM: Pinus radiata

<400> SEQUENCE: 2
aaactcgaca gcaaatatga tttagattat gacctagaaa taagcatagc attaaagcat

60

atacataaca agcggtgata tactctgact gccactgtac ttgaggaaag gtagtggact

120

ctgctcaggt acattagttt ggtaaggttg gcttggcttc tgggtaatat gagaagtaaa

180

gaagtaaaag gtatttgact ctagtcaagt acattggatt gcctttgtcg gggcttggat

240

ggcttgggtt cgtgtgagaa gccaacaatt tataagaaat atataaaata aaaaataaaa

300

aaatttaagt gttggaagtg aaaacggtgg ggcagaaata tacacagaag agtactttaa

360

caatgcgcaa ccaaggcaga ttcacaactt gatttctgga cctcgaatac gagataatgg

420

tggtaagaaa taaaggaaga gtggagtgca tttgaaaatg aatggagagc gcacaaaatg

480

gaggacgaat aaatgaaata taatgcaaga gtgcatttcc ctattatttc cagaaatgta

540

tatgtggggt cggcattcac atgggcgtcg cattcagggg gtgtcatagc ggtcctttga

600

ttgcagtgtg ggagttgcaa catgtaccaa caaatccatt catcccaaaa cctaaattta

660

tcctctccat tactattacc tacacctata cctagtaaat atgtcctgcc ttgtaactcc

720

tccactgcct gcacacgtct tagtcaatcc atctgccttc aaataggcat tattttgttc

780

tttcccctcc gactgaaagg ctatcgaccg accgaccgct catcttcttc ttctgcgcaa

840

ttttttctgc tggatcatca tcattaccat catcgccatc cccaccatca tcatcatgat

900

ggtatctcta tctctccctg gcaatcgatt gtagaggaaa ggaagaggga aggggcatat

960

gtattgatca acctacccga aaaaacaatc tgatcagccc tgctcaatct tgcttataaa

1020

tctcttatcc actgttcaat cattcaggtt tcttcccact ttcaagcaaa ggcgcccgga

1080

ttggccgtgt tcttagattt tcaggtactt aaatggacaa tattccccac ctgaagccgt

1140

tctgaaaaag atttgtttgt agaaacaaac gattgtaata tttgcttaag ttgagcttaa

1200

ggggtttggt acctaacttg ccttgtggtt atttgtttct cagaactcgg gctgcgtcca

1260

actgtaggaa cgaaccagca caaggggttg cagcttttgc tgttgctgtt gcgcccattg

1320
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cttttggact ggtattagta gttgcagctt tgttttgcat acgctgtgag gatctgtgcg

1380

cggaaatttt gtgtacaaat c

1401

<210>
<211>
<212>
<213>
<220>
<221>
<222>
<223>
<300>
<301>
<302>
<303>
<304>
<305>
<306>
<307>
<308>
<309>
<313>

SEQ ID NO 3
LENGTH: 909
TYPE: DNA
ORGANISM: Pinus radiata
FEATURE:
NAME/KEY: CDS
LOCATION: (1)..(669)
OTHER INFORMATION: Pinus radiata MADS box protein mRNA, complete
cds
PUBLICATION INFORMATION:
AUTHORS: Jun-Jun, Liu
Podila, G K.
TITLE: Not applicable
JOURNAL: Direct submission
VOLUME: ISSUE: PAGES: -DATE: 1997-09-09
DATABASE ACCESSION NUMBER: Genbank AF023615
DATABASE ENTRY DATE: 1999-01-26
RELEVANT RESIDUES: 1 TO 909

<400> SEQUENCE: 3
atg ggt
Met Gly
1

cgt ggg aag att gag ata aag agg att gaa aat act acg aac
Arg Gly Lys lie Glu lie Lys Arg lie Glu Asn Thr Thr Asn
5
10
15

48

cga cag
Arg Gin

gtc act ttc tgc aag cgc cga aat ggt tta tta aag aag gcg
Val Thr Phe Cys Lys Arg Arg Asn Gly Leu Leu Lys Lys Ala
20
25
30

96

tat gaa
Tyr Glu

tta tea gtt ett tgt gat gca gaa gtg gcc etc ate gtc ttc
Leu Ser Val Leu Cys Asp Ala Glu Val Ala Leu lie Val Phe
35
40
45

144

tcc age
Ser Ser
50

aga ggg aga ett tat gaa ttt gcc aac cac age gtg aag agg
Arg Gly Arg Leu Tyr Glu Phe Ala Asn His Ser Val Lys Arg
55
60

192

acg att
Thr lie
65

gag agg tac aag aag act tgc gtt gac aac aac cac gga ggg
Glu Arg Tyr Lys Lys Thr Cys Val Asp Asn Asn His Gly Gly
70
75
80

240

gcg ata
Ala lie

tea gag tcc aat tet cag tat tgg caa cag gag get ggt aaa
Ser Glu Ser Asn Ser Gin Tyr Trp Gin Gin Glu Ala Gly Lys
85
90
95

288

etc aga
Leu Arg

caa cag att gac att ttg caa aat gca aat agg cat ttg atg
Gin Gin lie Asp lie Leu Gin Asn Ala Asn Arg His Leu Met
100
105
110

336

ggt gac
Gly Asp

ggg ett aca get ttg aac att aag gaa etc aag caa ett gag
Gly Leu Thr Ala Leu Asn lie Lys Glu Leu Lys Gin Leu Glu
115
120
125

384

gtt cga
Val Arg
130

ett gaa aaa gga ate age cga gtg cga tcc aaa aag aac gag
Leu Glu Lys Gly lie Ser Arg Val Arg Ser Lys Lys Asn Glu
135
140

432

atg ttg
Met Leu
145

ett gaa gag ate gac ate atg cag aga agg gaa cac ata ett
Leu Glu Glu lie Asp lie Met Gin Arg Arg Glu His lie Leu
150
155
160

480

ate cag
lie Gin

gag aat gag att ett cgc age aag ata gcc gag tgt cag aat
Glu Asn Glu lie Leu Arg Ser Lys lie Ala Glu Cys Gin Asn
165
170
175

528

age cac
Ser His

aac acg aac atg tta tea get ccg gaa tat gat gca ctg ccc
Asn Thr Asn Met Leu Ser Ala Pro Glu Tyr Asp Ala Leu Pro
180
185
190

576

gca ttc gac tet cga aat ttc eta cat gca aat eta ate gat gcg gcc

624
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-continued

Ala Phe Asp Ser Arg Asn Phe Leu His Ala Asn Leu lie Asp Ala Ala
195
200
205
cat cac tat gca cat cag gaa caa aca acg ctt cag ctt ggc tga
His His Tyr Ala His Gin Glu Gin Thr Thr Leu Gin Leu Gly
210
215
220

669

acgttgaagc ggtggacgct taaaactcaa tcaaggcacc cgaaaaatat gctagtaacc

729

ttgaatgaga ttcagagtcg aaatattgcg aggcaagagc acaatggaag agatagctcc

789

tagtatgaat atggatttat gatattaaca tatggtttgt cagctttaaa tatagctgtt

849

tgaaacaaag aatacaacat attagctagt atttttttgg cgcatgttat ctttctgttg

909

<210>
<211>
<212>
<213>

SEQ ID NO 4
LENGTH: 222
TYPE: PRT
ORGANISM: Pinus radiata

<400> SEQUENCE: 4
Met Gly Arg Gly Lys lie Glu lie Lys Arg lie Glu Asn Thr Thr Asn
1
5
10
15
Arg Gin Val Thr Phe Cys Lys Arg Arg Asn Gly Leu Leu Lys Lys Ala
20
25
30
Tyr Glu Leu Ser Val Leu Cys Asp Ala Glu Val Ala Leu lie Val Phe
35
40
45
Ser Ser Arg Gly Arg Leu Tyr Glu Phe Ala Asn His Ser Val Lys Arg
50
55
60
Thr lie Glu Arg Tyr Lys Lys Thr Cys Val Asp Asn Asn His Gly Gly
65
70
75
80
Ala lie Ser Glu Ser Asn Ser Gin Tyr Trp Gin Gin Glu Ala Gly Lys
85
90
95
Leu Arg Gin Gin lie Asp lie Leu Gin Asn Ala Asn Arg His Leu Met
100
105
110
Gly Asp Gly Leu Thr Ala Leu Asn lie Lys Glu Leu Lys Gin Leu Glu
115
120
125
Val Arg Leu Glu Lys Gly lie Ser Arg Val Arg Ser Lys Lys Asn Glu
130
135
140
Met Leu Leu Glu Glu lie Asp lie Met Gin Arg Arg Glu His lie Leu
145
150
155
160
lie Gin Glu Asn Glu lie Leu Arg Ser Lys lie Ala Glu Cys Gin Asn
165
170
175
Ser His Asn Thr Asn Met Leu Ser Ala Pro Glu Tyr Asp Ala Leu Pro
180
185
190
Ala Phe Asp Ser Arg Asn Phe Leu His Ala Asn Leu lie Asp Ala Ala
195
200
205
His His Tyr Ala His Gin Glu Gin Thr Thr Leu Gin Leu Gly
210
215
220

<210>
<211>
<212>
<213>
<220>
<221>
<222>
<223>

SEQ ID NO 5
LENGTH: 1012
TYPE: DNA
ORGANISM: Arabidopsis thaliana
FEATURE:
NAME/KEY: CDS
LOCATION: (16 )..(795)
OTHER INFORMATION: Arabidopsis thaliana ribonuclease (RNS2) mRNA,
complete cds
<300> PUBLICATION INFORMATION:
<301> AUTHORS: Taylor, C B.
Bariola, P A.
delCardayre, S B.
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-continued

<302>
<303>
<304>
<305>
<306>
<307>
<308>
<309>
<313>

Raines, R T.
Green, P J.
TITLE: RNS2 : a senescence-associated RNase of Arabidopsis that
diverged from the S-RNases before speciation
JOURNAL: Proc. Natl. Acad. Sci. U.S.A.
VOLUME: 90
ISSUE: 11
PAGES: 5118-5122
DATE: 1993
DATABASE ACCESSION NUMBER: Genbank
DATABASE ENTRY DATE: 1994-10-30
RELEVANT RESIDUES: 1 TO 1012

<400> SEQUENCE: 5
atcgaattaa agtca atg gcg tea cgt tta tgt ett etc ett etc gtt geg
Met Ala Ser Arg Leu Cys Leu Leu Leu Leu Val Ala
1
5
10

51

tgt ate gee gga gca ttt gcc gga gac gtc ate gaa etc aat ega tet
Cys lie Ala Gly Ala Phe Ala Gly Asp Val lie Glu Leu Asn Arg Ser
15
20
25

99

cag agg gag ttc gat tat ttc get eta tet ett caa tgg cct gga acc
Gin Arg Glu Phe Asp Tyr Phe Ala Leu Ser Leu Gin Trp Pro Gly Thr
30
35
40

147

tat tgc cgt gga act ege cat tgt tgc tcc aaa aac get tgc tgc aga
Tyr Cys Arg Gly Thr Arg His Cys Cys Ser Lys Asn Ala Cys Cys Arg
45
50
55
60

195

ggc tec gat get cca act caa ttc aca att cat ggg tta tgg cct gac
Gly Ser Asp Ala Pro Thr Gin Phe Thr lie His Gly Leu Trp Pro Asp
65
70
75

243

tat aac gat ggt teg tgg cct tea tgt tgt tat ega tet gac ttt aaa
Tyr Asn Asp Gly Ser Trp Pro Ser Cys Cys Tyr Arg Ser Asp Phe Lys
80
85
90

291

gag aag gag att tea aeg ttg atg gat ggt ett gag aag tac tgg cct
Glu Lys Glu lie Ser Thr Leu Met Asp Gly Leu Glu Lys Tyr Trp Pro
95
100
105

339

agt etc agt tgt ggt tet cca tea tea tgc aat ggt ggg aaa ggg tea
Ser Leu Ser Cys Gly Ser Pro Ser Ser Cys Asn Gly Gly Lys Gly Ser
110
115
120

387

ttt tgg ggc cac gag tgg gag aaa cat ggg act tgt tet tet cct gtt
Phe Trp Gly His Glu Trp Glu Lys His Gly Thr Cys Ser Ser Pro Val
125
130
135
140

435

ttt cat gat gag tat aat tac ttc ett acc aca ett aat etc tac ttg
Phe His Asp Glu Tyr Asn Tyr Phe Leu Thr Thr Leu Asn Leu Tyr Leu
145
150
155

483

aag cat aat gtc aeg gat gtc ett tat caa get ggc tat gtt get tcc
Lys His Asn Val Thr Asp Val Leu Tyr Gin Ala Gly Tyr Val Ala Ser
160
165
170

531

aac agt gaa aag tat cct eta gga ggt ate gta aca gcc att cag aat
Asn Ser Glu Lys Tyr Pro Leu Gly Gly lie Val Thr Ala lie Gin Asn
175
180
185

579

gca ttt cat ate ace cct gaa gtg gtt tgc aaa aga gat gca ate gat
Ala Phe His lie Thr Pro Glu Val Val Cys Lys Arg Asp Ala lie Asp
190
195
200

627

gaa ata cgt ata tgc ttc tat aaa gat ttt aag ccc agg gac tgt gtt
Glu lie Arg lie Cys Phe Tyr Lys Asp Phe Lys Pro Arg Asp Cys Val
205
210
215
220

675

ggt tea caa gat ttg aca tet aga aag tea tgc ccc aag tac gta agt
Gly Ser Gin Asp Leu Thr Ser Arg Lys Ser Cys Pro Lys Tyr Val Ser
225
230
235

723

ttg ccg gaa tac aeg cca tta gat ggt gaa get atg gtt ctg aag atg
Leu Pro Glu Tyr Thr Pro Leu Asp Gly Glu Ala Met Val Leu Lys Met
240
245
250

111
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23
-continued
cca aca gaa aga gaa get ett tga atcggaaaag atgggagctt tgttatcttc
Pro Thr Glu Arg Glu Ala Leu
255

825

tgagagacaa tacatacatg tctctgatgt tgtaacttta ctaccaaaac ctataaagat

885

tggcttattt cgttctattg gatatgtatc atcattactg gtaaatcaag tttctttcta

945

ataatgtaga agatcagaaa atccataaga agatatcaac atttgagttc tatggtaaaa

1005

aaaaaaa

1012

<210>
<211>
<212>
<213>

SEQ ID NO 6
LENGTH: 259
TYPE: PRT
ORGANISM: Arabidopsis thaliana

<400> SEQUENCE: 6
Met Ala Ser Arg Leu Cys Leu Leu Leu Leu Val Ala Cys lie Ala Gly
1
5
10
15
Ala Phe Ala Gly Asp Val lie Glu Leu Asn Arg Ser Gin Arg Glu Phe
20
25
30
Asp Tyr Phe Ala Leu Ser Leu Gin Trp Pro Gly Thr Tyr Cys Arg Gly
35
40
45
Thr Arg His Cys Cys Ser Lys Asn Ala Cys Cys Arg Gly Ser Asp Ala
50
55
60
Pro Thr Gin Phe Thr lie His Gly Leu Trp Pro Asp Tyr Asn Asp Gly
65
70
75
80
Ser Trp Pro Ser Cys Cys Tyr Arg Ser Asp Phe Lys Glu Lys Glu lie
85
90
95
Ser Thr Leu Met Asp Gly Leu Glu Lys Tyr Trp Pro Ser Leu Ser Cys
100
105
110
Gly Ser Pro Ser Ser Cys Asn Gly Gly Lys Gly Ser Phe Trp Gly His
115
120
125
Glu Trp Glu Lys His Gly Thr Cys Ser Ser Pro Val Phe His Asp Glu
130
135
140
Tyr Asn Tyr Phe Leu Thr Thr Leu Asn Leu Tyr Leu Lys His Asn Val
145
150
155
160
Thr Asp Val Leu Tyr Gin Ala Gly Tyr Val Ala Ser Asn Ser Glu Lys
165
170
175
Tyr Pro Leu Gly Gly lie Val Thr Ala lie Gin Asn Ala Phe His lie
180
185
190
Thr Pro Glu Val Val Cys Lys Arg Asp Ala lie Asp Glu lie Arg lie
195
200
205
Cys Phe Tyr Lys Asp Phe Lys Pro Arg Asp Cys Val Gly Ser Gin Asp
210
215
220
Leu Thr Ser Arg Lys Ser Cys Pro Lys Tyr Val Ser Leu Pro Glu Tyr
225
230
235
240
Thr Pro Leu Asp Gly Glu Ala Met Val Leu Lys Met Pro Thr Glu Arg
245
250
255
Glu Ala Leu

<210>
<211>
<212>
<213>
<220>
<223>
<220>
<221>

SEQ ID NO 7
LENGTH: 20
TYPE: DNA
ORGANISM: Artificial Sequence
FEATURE:
OTHER INFORMATION: Description of Artificial Sequence:Made in lab
FEATURE:
NAME/KEY: modified_base
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V
V
V

V

to

to
to

A

A

to

A

A

to

<222> LOCATION: ( 3 )
<223> OTHER INFORMATION : n=i
<220> FEATURE:
NAME/KEY: modified._base
<222> LOCATION: ( 6 )
<223> OTHER INFORMATION : n=i
<220> FEATURE:
NAME/KEY: modified._base
<222> LOCATION: ( 9 )
<223> OTHER INFORMATION : n=i
<220> FEATURE:
NAME/KEY: modified._base
<222> LOCATION: ( 1 2 )
<223> OTHER INFORMATION : n=i
<220> FEATURE:
NAME/KEY: modified._base
<222> LOCATION: ( 1 5 )
<223> OTHER INFORMATION : n=i
A

V

o
o

SEQUENCE: 7

gcngtnagny cntcncccat

<210>
<211>
<212>
<213>
<220>
<223>
<220>
<221>
<222>
<223>
<220>
<221>
<222>
<223>
<220>
<221>
<222>
<223>

20

SEQ ID NO 8
LENGTH: 17
TYPE: DNA
ORGANISM: Artificial Sequence
FEATURE:
OTHER INFORMATION: Description of Artificial Sequence:Made in lab
FEATURE:
NAME/KEY: modified_base
LOCATION: (6)
OTHER INFORMATION: n=i
FEATURE:
NAME/KEY: modified_base
LOCATION: (12)
OTHER INFORMATION: n=i
FEATURE:
NAME/KEY: modified_base
LOCATION: (15)
OTHER INFORMATION: n=i

<400> SEQUENCE: 8
aaycgncarg tnacntt

<210>
<211>
<212>
<213>
<220>
<223>

17

SEQ ID NO 9
LENGTH: 30
TYPE: DNA
ORGANISM: Artificial Sequence
FEATURE:
OTHER INFORMATION: Description of Artificial Sequence:Made in lab

<400> SEQUENCE: 9
cgccttcttc aataaaccat ttcggcgctt

<210>
<211>
<212>
<213>
<220>
<223>

30

SEQ ID NO 10
LENGTH: 30
TYPE: DNA
ORGANISM: Artificial Sequence
FEATURE:
OTHER INFORMATION: Description of Artificial Sequence:Made in lab

<400> SEQUENCE: 10
gacctgtcgg ttcgtagtat tttcaatcct

<210>
<211>
<212>
<213>
<220>
<223>

SEQ ID NO 11
LENGTH: 30
TYPE: DNA
ORGANISM: Artificial Sequence
FEATURE:
OTHER INFORMATION: Description of Artificial Sequence:Made in lab

30
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28
-continued

V

A
O
O

SEQUENCE: 11

ttcgtcctcc attttgtgcg ctctccattc

<2 10>
<2 11>
<2 12>
<2 13>
<220>
<223>

SEQ ID NO 12
LENGTH: 30
TYPE: DNA
ORGANISM: Artificial Sequence
FEATURE:
OTHER INFORMATION: Description of Artificial Sequence:Made in lab

A

V

o
o

SEQUENCE: 12

gcactccact cttcctttat ttcttaccac

<2 10>
<2 11>
<2 12>
<2 13>
<220>
<223>
A

V

o
o

SEQUENCE: 13

V

I'd
O

A

A

V

o
o

SEQUENCE: 14

V

I'd
O

A

A

V

o
o

SEQUENCE: 15

V

I'd
O

A

A

V

o
o

V

I'd
O

A

18

SEQ ID NO 16
LENGTH: 20
TYPE: DNA
ORGANISM: Artificial Sequence
FEATURE:
OTHER INFORMATION: Description of Artificial Sequence:Made in lab
SEQUENCE: 16

gaacaagatg gattgcacgc

<2 11>
<2 12>
<2 13>
<220>
<223>

18

SEQ ID NO 15
LENGTH: 18
TYPE: DNA
ORGANISM: Artificial Sequence
FEATURE:
OTHER INFORMATION: Description of Artificial Sequence:Made in lab

gtaagcccgt cacccatc

<2 11>
<2 12>
<2 13>
<220>
<223>

27

SEQ ID NO 14
LENGTH: 18
TYPE: DNA
ORGANISM: Artificial Sequence
FEATURE:
OTHER INFORMATION: Description of Artificial Sequence:Made in lab

ttgtgtacaa atcatggg

<2 11>
<2 12>
<2 13>
<220>
<223>

30

SEQ ID NO 13
LENGTH: 27
TYPE: DNA
ORGANISM: Artificial Sequence
FEATURE:
OTHER INFORMATION: Description of Artificial Sequence:Made in lab

agttacttaa caatgcgcaa ccaaggc

<2 11>
<2 12>
<2 13>
<220>
<223>

30

20

SEQ ID NO 17
LENGTH: 20
TYPE: DNA
ORGANISM: Artificial Sequence
FEATURE:
OTHER INFORMATION: Description of Artificial Sequence:Made in lab

A

V

o
o

SEQUENCE: 17

gaagaactcg tcaagaaggc

20
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What is claimed is:
17. The construct according to claim 5 which further
includes:
1. An isolated polynucleotide which has the nucleotide
sequence of SEQ ID NO. 1 and which has the ability, when
(d) a selection marker sequence.
18. The construct according to claim 17 in which said
operably associated with a further nucleotide sequence
encoding a peptide, to promote transcription of said further 5 selection marker sequence is the NPTII gene.
nucleotide sequence, or an isolated polynucleotide which
19. A transgenic plant cell which includes a construct
has at least 95% nucleotide sequence identity to SEQ ID
according to claim 5.
NO. 1 and which is a functionally equivalent variant of SEQ
20. A transgenic plant which includes a construct accord
ID NO. 1.
ing to claim 8 .
2. An isolated plant reproductive tissue specific promoter 10
21. A transgenic plant which contains a polynucleotide
which has the nucleotide sequence of SEQ ID NO. 1 or a
according to claim 1 or a promoter according to claim 5,
functionally equivalent variant thereof which has at least
which plant has a reduced reproductive capacity.
95% nucleotide sequence identity with SEQ ID NO. 1.
22. The transgenic plant according to claim 21 wherein in
3. An isolated plant reproductive tissue promoter which
said plant said polynucleotide or said promoter is opera
has the nucleotide sequence of SEQ ID NO. 2.
15 tively associated with a nucleotide sequence encoding a
peptide, which when expressed in reproductive tissue of the
4. A DNA construct which comprises as operably linked
plant, causes the plant’s reproductive organs to abort, rede
components:
fine as vegetative or stop development.
(a) a polynucleotide having activity as a transcriptional
23. The transgenic plant according to claim 21 wherein in
promoter according to claim 1;
20 said plant said polynucleotide or promoter is operatively
(b) an open reading frame polynucleotide coding for a
associated with a nucleotide sequence encoding a RNAse.
peptide; and
24. The transgenic plant according to claim 23 in which
(c) a termination sequence.
the RNAse has the sequence of SEQ ID NO. 6.
5. A DNA construct which comprises as operably linked
25. The transgenic plant according to claim 20 wherein
components:
25 said plant is a coniferous plant.
(a) a promoter sequence as given in SEQ ID NO. 1 or a
26. The transgenic plant according to claim 25 which is a
functionally equivalent variant thereof which has at
coniferous plant of the Firms genus.
least 95% homology to SEQ ID NO. 1 or a promoter
27. The transgenic plant according to claim 26 which is a
sequence as given in SEQ ID NO. 2;
member of a species selected from the group consisting of
(b) an open reading frame polynucleotide coding for a 30 Firms radiata, Firms taeda, Firms elliotti, Firms clausa,
peptide; and
Firms palustrus, Firms echinata, Firms ponderosa, Firms
Jeffrey, Firms resinosa, Firms rigida, Firms banksiana, Firms
(c) a termination sequence.
serotina, Firm s strobus, F irm s m o n tico la , Firm s
6. The construct as claimed in claim 4 or claim 5 in which
lambertiana, Firms virginiana, Firms contorta, Firms
the open reading frame is in a sense orientation.
7. The construct as claimed in claim 4 or claim 5 in which 35 cariboea, Firms pinaster, Pinus brutia, Pinus eldarica,
Pinus coulteri, Pinus nigra, Pinus sylvestris, Pinus
the open reading frame is in an anti-sense orientation.
tecunumannii, Pinus keysia, Pinus oocarpa and Pinus maxi8. The construct according to claim 5 wherein said open
numoii; and hybrids between any of the above species.
reading frame encodes a peptide having SEQ ID NO. 4.
9. The construct according to claim 6 wherein said open
28. The transgenic plant according to claim 20 wherein
reading frame polynucleotide encodes a peptide which, 40 said plant is a tree.
29. The transgenic plant according to claim 28 which is a
when expressed in reproductive tissue of a plant, causes said
member of the Eucalyptus genus.
plant’s reproductive organs to abort.
10. The construct according to claim 6 wherein said open
30. The transgenic plant according to claim 26 which is a
reading frame polynucleotide encodes a peptide which,
member of a species selected from the group consisting of
when expressed in reproductive tissue of a plant, causes said 45 E ucalyptus alba, Eucalyptus bancroftii, E ucalyptus
plant’s reproductive organs to redefine themselves as veg
botyroides, Eucalyptus bridgesiana, Eucalyptus calophylla,
etative.
Eucalyptus camaldulensis, Eucalyptus citriodora, Eucalyp
tus cladocalyx, Eucalyptus coccifera, Eucalyptus curtisii,
11. The construct according to claim 6 wherein said open
Eucalyptus dalrympleana, Eucalyptus deglupta, Eucalyptus
reading frame polynucleotide encodes a peptide which,
when expressed in reproductive tissue of a plant, causes said 50 delagatensis, Eucalyptus diversicolor, Eucalyptus dunnii,
Eucalyptus ficifolia, Eucalyptus globulus, Eucalyptus
plant’s reproductive organs to stop development.
gomphocephala, Eucalyptus gunnii, Eucalyptus henryi,
12. The construct according to claim 6 wherein said open
Eucalyptus laevopinea, Eucalyptus macarthurii, Eucalyptus
reading frame polynucleotide encodes a peptide which,
m acrorhyncha, E u c a ly p tu s m a culata, E u ca lyp tu s
when expressed in reproductive tissue of a plant, causes cell
death.
55 marginata, Eucalyptus megacarpa, Eucalyptus melliodora,
Eucalyptus nicholii, Eucalyptus nitens, Eucalyptus nova13. The construct according to claim 12 wherein the
anglica, Eucalyptus obliqua, Eucalyptus obtusiflora, Euca
peptide which causes cell death is selected from the group
lyptus oreades, E uca lyp tu s pauciflora, E ucalyptus
consisting of diphtheria toxin A and Barnase.
polybractea, Eucalyptus regnans, Eucalyptus resinifera,
14. The construct according to claim 12 wherein the
peptide which causes cell death is an RNAse.
60 Eucalyptus robusta, Eucalyptus rudis, Eucalyptus saligna,
Eucalyptus sideroxylon, Eucalyptus stuartiana, Eucalyptus
15. The construct according to claim 14 wherein said
tereticornis, Eucalyptus torelliana, Eucalyptus urnigera,
RNase is encoded by the nucleotide sequence of SEQ ID
Eucalyptus urophylla, Eucalyptus viminalis, Eucalyptus
NO. 5.
viridis, Eucalyptus wandoo and Eucalyptus youmanni; and
16. The construct according to claim 6 wherein said open
reading frame polynucleotide encodes a peptide which, 65 hybrids between any of the above species.
when expressed in reproductive tissue of a plant, causes an
alteration in the timing of flowering of said plant.
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Line 6, delete "COT" and replace with - CGT
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Column 12,
Line 9, delete "f" and replace with - of
Line 21, delete "ethod" and replace with - method
Line 40, delete "GAT GCA" and replace with - GAT GGA
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Line 43, delete "claim 26 and replace with - claim 29
"
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